As of 2025-05-15, the EV/EBITDA ratio of Crescita Therapeutics Inc (CTX.TO) is -0.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTX.TO's latest enterprise value is 1.64 mil CAD. CTX.TO's TTM EBITDA according to its financial statements is -1.74 mil CAD. Dividing these 2 quantities gives us the above CTX.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 2.3x - 9.4x | 2.9x |
| Forward P/E multiples | 1.5x - 10.1x | 1.9x |
| Fair Price | 0.23 - (0.41) | 0.22 |
| Upside | -56.3% - -178.0% | -57.7% |
| Date | EV/EBITDA |
| 2025-05-14 | -0.83 |
| 2025-05-13 | -0.94 |
| 2025-05-12 | -1.16 |
| 2025-05-07 | -1.27 |
| 2025-05-06 | -1.49 |
| 2025-05-05 | -1.16 |
| 2025-05-02 | -1.49 |
| 2025-04-30 | -1.49 |
| 2025-04-29 | -1.49 |
| 2025-04-28 | -1.49 |
| 2025-04-24 | -1.38 |
| 2025-04-22 | -1.38 |
| 2025-04-21 | -1.27 |
| 2025-04-16 | -1.60 |
| 2025-04-15 | -1.70 |
| 2025-04-14 | -1.49 |
| 2025-04-09 | -0.94 |
| 2025-04-07 | -1.05 |
| 2025-04-02 | -1.27 |
| 2025-04-01 | -1.49 |
| 2025-03-31 | -1.49 |
| 2025-03-28 | -1.49 |
| 2025-03-25 | -1.49 |
| 2025-03-24 | -1.60 |
| 2025-03-21 | -1.27 |
| 2025-03-17 | -0.83 |
| 2025-03-12 | -0.72 |
| 2025-03-10 | -1.16 |
| 2025-03-06 | -1.16 |
| 2025-03-05 | -1.60 |
| 2025-03-04 | -1.38 |
| 2025-03-03 | -1.38 |
| 2025-02-27 | -1.27 |
| 2025-02-25 | -1.27 |
| 2025-02-21 | -1.27 |
| 2025-02-19 | -1.27 |
| 2025-02-18 | -1.27 |